When a Study Cast Doubt on a Heart Pill, the Drug Company Turned to Tom Price
By Robert Faturechi,
ProPublica
| 01. 19. 2017
After hearing from a company whose CEO was a campaign contributor, a congressional aide to Donald Trump’s HHS nominee repeatedly pushed a federal health agency to remove a critical drug study from its website.
The $3 pill known as BiDil was already a difficult sell when a Georgia-based pharmaceutical company bought the marketing rights a few years ago. A treatment for African Americans suffering from heart failure, BiDil had never really caught on, forcing the drug company that developed it to take a buyout offer. One strike against the drug was a 2009 study that raised questions about its safety and effectiveness.
So last summer, the new owner of the drug, Arbor Pharmaceuticals LLC of Atlanta, sought to get the study taken down from a government website. For help, the company turned to the office of a congressman to whom the CEO had given the maximum $2,700 campaign donation — Rep. Tom Price, the Georgia Republican nominated by Donald Trump to become head of the Department of Health and Human Services.
Over the next few months, one of Price’s aides...
Related Articles
By Matthew Herper, Stat | 07.01.2026
Researchers have created what they say may count as the first synthetic cell, and have started a public benefit corporation to share the technology with other scientists. It’s a piece of science that generates as many questions as answers. They...
By Tory Shepherd, The Guardian | 07.17.2026
Over eight years, Ethan and his wife went through nine rounds of IVF in Melbourne.
They travelled to Spain for two more, without success.
“I thought maybe the universe had decided we’re not supposed to have kids,” says Ethan, who...
By Oscar Lopez, The Guardian | 07.19.2026
Diogo Amaro met his future husband, Loup, in Paris and from the first date, he made one thing clear: he wanted to have children.
“Right off the bat, I was like: ‘If I’m going to be in a relationship with...
By Emily Baumgaetner Nunn, The New York Times | 07.20.2026
The National Institutes of Health recently announced a remarkable achievement: the world’s largest database of human genomes, a repository of information that the agency says will help usher in a new era in personalized medicine.
Scientists are already developing clinical...
